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Abstract - SOX2 is a key transcription factor in embryonic development representing a universal marker of pluripotent 
stem cells. Based on the functional redundancy and overlapping expression patterns of SOXB1 subgroup members 
during development, the goal of this study has been to analyze if some aspects of regulation of expression are preserved 
between human SOX2 and SOX3 genes. Thus, we have tested several transcription factors previously demonstrated to 
play roles in controlling SOX3 gene activity for potential participation in the regulation of SOX2 gene expression in 
NT2/D1 cells. Here we report on the activation of SOX2 expression by ubiquitous transcription factors (NF-Y, Sp1 and 
MAZ), TALE family members (Pbx1 and Meis1), as well as liganded RXRα. Elucidating components involved in the 
regulation of SOX gene expression represent a valuable contribution in unraveling the regulatory networks operating in 
pluripotent embryonic cells. 
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INTRODUCTION 
The SOX gene family encodes a highly conserved 
group of transcription factors that control cell fate 
and differentiation in numerous key developmental 
and physiological processes (reviewed in Lefebvre  
et al., 2007). SOX transcription factors carry an 
DNA-binding HMG domain and perform their 
functions by interacting with other transcription 
factors in a manner highly dependent on cell type 
and promoter context (Kamachi  et al., 2000). They 
show both classical and architectural modes of 
action, either activating or repressing specific target 
genes (Wilson and Koopman, 2002). Based on 
phylogenetic analysis of their HMG domains, Sox 
genes are divided into 10 distinct groups designated 
A-J (Bowles  et al., 2000).  
SOX2, together with SOX1 and SOX3, belongs 
to the SOXB1 subgroup of transcriptional activators 
(Uchikawa  et al., 1999). They are panneurally 
expressed and have redundant roles in maintaining 
the broad developmental potential and identity of 
neural stem cells (reviewed in Lefebvre  et al., 2007). 
Their inhibition in the vertebrate embryo results in 
premature differentiation of neural precursors, 
while their overexpression leads to inhibition of 
neurogenesis (reviewed in Lefebvre  et al., 2007). In 
addition to regulating the progression of neu-
rogenesis, SOXB1 transcription factors (TFs) also 
function in post-mitotic neurons (Kiefer, 2007).  
Sox2 is a key TF in embryonic development and 
represents an universal marker of pluripotent stem 
cells (Papanayotou  et al., 2008). Numerous studies 
recognize Sox2, together with Nanog and Oct3/4 
transcription factors, as crucial for maintaining the 
pluripotent stem cell phenotype (Rodda et al., 
2005). It has recently been shown that Sox2, 
together with Oct3/4, c-Myc and Klf4, forms a 
quartet of transcription factors that is sufficient to 
induce pluripotent stem cell properties in embryo-200 MILENA  MILIVOJEVIĆ  ET AL. 
nic and adult fibroblasts (Takahashi and Yamanaka, 
2006). Thus, it has been proposed that Sox2 
probably functions as a molecular rheostat that 
controls the expression of a critical set of embryonic 
genes, as well as the self-renewal and differentiation 
of embryonic stem (ES) cells (Kopp  et al., 2008).  
Although  Sox2 is expressed panneurally, its 
transcriptional  regulation in the CNS is differen-
tially regulated by regional signals, according to the 
specific developmental needs of the different re-
gions of the nervous system (Catena  et al., 2004). 
Therefore, it is not surprising that the complex 
expression profile of Sox2 is controlled by multiple 
regulatory elements, widely scattered in a genomic 
region centered around the gene and with distinct 
spatio-temporal specificities (reviewed in Kamachi  
et al., 2009). Namely, eleven functionally defined 
enhancers have been described within 50-kb of the 
chicken genomic region encompassing the Sox2 
gene (~ 17-kb upstream and ~ 33-kb downstream 
of the Sox2 gene). DNA sequences of these enhan-
cers are conserved in a wide range of vertebrate spe-
cies, where they are embedded in much longer 
stretches of highly conserved, non-functional se-
quences surrounding the Sox2 gene (reviewed in 
Kamachi  et al., 2009).  
Apart from these far-distance Sox2 enhancers’ 
studies, functional analyses  of the mouse Sox2 
promoter have been performed as well. Namely, it 
has been shown that the regulatory region (-528 to 
+238) of the Sox2 gene is able to support the ex-
pression of the reporter gene in mouse embryonal 
carcinoma (EC) cells, preferentially when they are 
in an undifferentiated state (Wiebe  et al., 2000). 
Moreover, it has been found that the same re-
gulatory region retains its activity when the EC and 
ES cells were induced to differentiate (Wiebe  et al., 
2000). It has also been revealed that the murine 
Sox2 promoter region, located -426 to +9, is able to 
regulate the expression of this gene via the agonistic 
and antagonistic action of AP2, Msx2, Pax6, Prox1 
and Six3 transcription factors (Lengler  et al., 2005).  
To date, the most widely characterized pluri-
potential EC cell line is the human NT2/D1 cell line 
that resembles early ES cells in morphology, antigen 
expression patterns, biochemistry, developmental 
potential, and gene regulation (Andrews, 1984). 
Upon culture in retinoic acid (RA), NT2/D1 cells 
differentiate into well-developed CNS-like neurons 
(Spinella  et al., 2003). Accordingly, these cells serve 
as a powerful in vitro model system for studying 
genes that promote and regulate human neural 
differentiation (Spinella  et al., 2003).  
We have previously described the modulation 
of SOX2 and SOX3 gene expression during the early 
phases of differentiation and neural induction of 
NT2/D1 cells by RA (Stevanovic, 2003). Also, we 
have performed extensive functional characteri-
zation of the human SOX3 promoter (Kovacevic   
Grujicic  et al., 2005) and demonstrated the invol-
vement of several transcription factors (TFs) in the 
regulation of expression of this gene (Kovacevic   
Grujicic et al., 2005; Krstic  et al., 2007; Mojsin  et 
al., 2006; Nikcevic  et al., 2008).  
Based on the functional redundancy and over-
lapping expression patterns of SOXB1 members 
during development, the goal of the present study 
has been to analyze whether some aspects of 
regulation of expression are preserved between 
human SOX2 and SOX3 genes.  
MATERIALS AND METHODS 
Cell culture 
NT2/D1 cells were maintained in Dulbecco’s mo-
dified Eagle’s medium (DMEM, high glucose) 
supplemented with 10% fetal bovine serum (FBS) 
and 2 mM L-glutamine at 37 ºC in 10% CO2. All 
indicated reagents were obtained from Invitrogen.  
Transfection 
In transfection experiments 2 x 10
6 NT2/D1 cells were 
seeded into a 10 cm dish and transfected with 5 μg of 
expression vectors (NF-YA, pCMVSp1, pCMV-MAZ,  
pCIPbx1b, pCIMeis1a and pCDNA3.1TGIF), or 1 μg 
of expression plasmid for nuclear receptor, pRS-
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generated by releasing mouse Pbx1b and Meis1a 
cDNAs from pGEM3zf-Pbx1b and MSCV-Meis1a, 
respectively (kind gift from Prof. Mark P. Kamps), 
and cloning in a pCI mammalian expression vector 
(Promega). Vector pBluescript (Stratagene) was used 
to adjust the total amount of DNA (up to 9 μg for 
RXRα, and up to 10 μg for all other expression 
vectors). Cells were transfected using the calcium 
phosphate precipitation method, as described (Nik-
cevic  et al., 2006). 
Western blot analysis 
Whole cell lysates (WCL) were prepared from 
either NT2/D1 cells alone, or transfected with 
expression vectors for particular transcription 
factors. In experiments where the nuclear 
receptor RXRα was involved, the day after 
transfection the cells were induced by 10μM all-
trans RA (Sigma) for a period of 48 h. For each 
WCL approximately 10
7 cells were scraped and 
twice washed in 1x phosphate-buffered saline. 
Cells were lysed for 30 min in 1 mL of cold lysis 
buffer (50 mM Tris–HCl, pH 8.0, 150 mM NaCl, 
1% Nonidet P-40) containing Protease inhibitor 
cocktail (Roche). Cell lysates were centrifuged at 
10 000 x g for 15 min at 4ºC. Supernatants were 
collected and stored at -80ºC. WCL samples were 
separated by SDS–PAGE in 10% resolving gel 
using Bio-Rad minigel apparatus and then 
electrotransferred to PVDF Immobilon P 
(Millipore). After blocking with 10% nonfat milk 
at room temperature for 1 h, the membranes were 
incubated with primary antibodies against SOX2 
(ab15830 - Abcam) and anti-α-tubulin (CP06-
CALBIOCHEM) under the same conditions. The 
membranes were then incubated with HRP-
conjugated anti-rabbit IgG or anti-mouse IgG 
(Amersham Pharmacia Biotech) for 1 h at room 
temperature. Immunoreactive bands were detec-
ted using an ECL kit (GE Healtcare). Antibodies 
for SOX2 and α-tubulin recognize bands of 42 
and 55 kDa, respectively.  
Immunoblots were digitalized and quantified with 
the ImageJ program (www.rsb.info.nih.gov/ij). α-
tubulin was employed to indicate the amounts of 
proteins used for the analysis. The quantities of the 
SOX2 protein level were calculated relative to the non-
transfected NT2/D1 cells (set as 1), and were indicated 
below the particular immunoreactive bands. 
Bioinformatic analysis 
Database searches were performed using the National 
Center for Biotechnology Information (NCBI).  
To analyze the SOX2 promoter region, the human 
genome sequence NT_005612.16 retrieved from 
NCBI was subjected to promoter prediction software 
PromoterInspector (http://www.genomatix.de). 
By applying ClustalW software (EMBL-EBI) and 
GeneDoc software version 2.6.003 (Nicholas Karl and 
Nicholas H. B. Jr 1997 Gene Doc: a tool for editing 
and annotating multiple sequence alignments. 
Distributed by authors), we performed an alignment 
of the predicted human SOX2 promoter sequence 
with the mouse orthologue (retrieved from genome 
sequence NW_001030719.1).  
Transcription factor binding sites within the se-
quences of interest were analyzed using MatInspec-
tor software (Genomatix, http://www.genomatix.de). 
All predicted transcription factor binding sites have 
core similarity 1. 
RESULTS AND DISCUSSION 
The study presented here was undertaken in order 
to examine the effect of selected transcription 
factors, which we have previously demonstrated to 
play roles in controlling SOX3 gene activity, for 
their potential participation in the regulation of 
SOX2 expression in a native context. Accordingly, 
we analyzed the effect of overexpression of the 
following TFs: ubiquitous  (NF-Y, Sp1, MAZ), 
TALE (PBX, MEIS, TGIF) and nuclear receptors 
(retinoid X receptor) on the SOX2 expression in 
NT2/D1 cells by Western blot analysis. Therefore, 
the goal of the present study has been to analyze 
whether some aspects of regulation of expression 
are preserved between human SOX2 and SOX3 
genes. 202 MILENA  MILIVOJEVIĆ  ET AL. 
 
Fig. 1. (A) and (B). Ubiquitous TFs: NF-YA, Sp1 and MAZ up-
regulate human SOX2 protein expression. Western blot
analyses of WCLs from NT2/D1 cells, non-transfected, or
transfected with expression vectors for indicated TFs were
performed using antibodies specific for SOX2 and α-tubulin, as 
indicated on the right. Quantitation of SOX2 protein level 
(relative to non-transfected NT2/D1 cells which was set as 1) is
shown below. 
Effect of ubiquitous transcription factors 
on SOX2 expression 
Effects of transcription factors NF-Y and Sp1 
The CCAAT box is a widespread eukaryotic pro-
moter element, recognized by a number of TFs such 
as c/EBP, MS-Y, CTF/NF-1 and NF-Y (Mantovani  
1998; Suzuki  et al., 2001). Among them, NF-Y is 
the only one that requires the CCAAT pen-
tanucleotide sequence (Dorn  et al., 1987). NF-Y is 
composed of three subunits (A, B and C), all ne-
cessary for DNA binding (Sinha  et al., 1995). Upon 
binding to DNA, NF-Y is able to bend the DNA, 
indicating that this factor may have an important 
architectural role (Ronchi  et al., 1995). Generally, 
NF-Y promotes and/or stabilizes the binding of TFs 
to nearby DNA-binding elements, attracts co-
activators and, consequently, enhances tran-
scription (Frontini et al., 2002; Ronchi  et al., 1995). 
Recently, we have shown that the human SOX3 
promoter possesses three CCAAT box control 
elements and that all of them mediate tran-
scriptional activation of the SOX3 gene by binding 
the transcription factor NF-Y (Krstic  et al., 2007). 
Therefore, the SOX3 gene is part of the emerging 
class of genes harboring multiple functional 
CCAAT boxes within their regulatory regions 
(Colter  et al., 2005; Salsi  et al., 2003).  
The majority of promoters contain only one 
CCAAT box (either in the forward or reverse 
orientation) present at positions between -60 and  
-100 (Mantovani  1998). This has been found to be 
the average distance from the tsp for functional 
CCAAT boxes in promoters that lack a TATA box 
(Mantovani  1998), such as Sox2/SOX2. Namely, the 
characterization of the murine Sox-2 promoter has 
revealed the presence of a consensus inverted 
CCAAT box motif that can bind the trimeric 
transcription factor NF-Y from nuclear extracts of 
murine F9 EC cells, and whose mutation signi-
ficantly reduces the expression of Sox-2 promo-
ter/reporter constructs (Wiebe  et al., 2000).  
When we overexpressed NF-Y subunit A in 
NT2/D1 cells, only a mild positive effect on human 
SOX2 expression was detected (Fig. 1A). This result 
led us to propose that it is very likely that, in 
addition to NF-Y, other TFs are necessary to enable 
the proper activation of the SOX2 promoter. One of 
the possible candidates might be the specificity 
protein 1 (Sp1). Sp1 is an ubiquitous, zinc-finger, 
transcription factor that binds GC/GT-rich pro-
moter elements (Kadonaga  et al., 1987). Activation 
of genes by Sp1 is highly complex, and is dependent 
on the gene promoter, cell context and interactions 
with other nuclear proteins (Pugh  and Tjian, 1990).  
Regarding the human SOX3 gene, we have 
shown that the Sp1 site within its minimal promo-
ter region is of functional relevance for its con-
stitutive expression in NT2/D1 cells (Kovacevic     INVOLVEMENT OF UBIQUITOUS AND TALE TRANSCRIPTION FACTORS  203 
Grujicic  et al., 2005). Here we have shown that in 
undifferentiated NT2/D1 cells overexpressed Sp1 
caused a significant increase in the SOX2 protein 
level (Fig. 1B).  
There are many examples of promoters that 
require the concerted action of Sp1 and NF-Y 
(discussed in Clem et al., 2003), both within a mini-
mal promoter region of approx. 100 bp upstream of 
the  tsp (Benfante  et al., 2005) and the extended 
promoter regulatory region (approx. 600 bp) 
(Magan  et al., 2003). Since the human SOX2 pro-
moter does not contain a TATA element, it is 
possible that this gene also requires the co-operative 
functional interaction between NF-Y and Sp1 in 
order to sustain its transcription. Moreover, since 
both NF-Y and Sp1 are ubiquitously expressed, it is 
quite possible that by enabling protein-protein 
interactions they co-operate in recruiting one or 
more neuro-specific co-activators, which subse-
quently activate the transcription of the SOX2 gene 
in a tissue-specific fashion in NT2/D1 cells. 
Effect of transcription factor MAZ 
We also included in our analysis the Myc-
associated zinc finger protein (MAZ). This protein 
was first identified as a TF bound to the promoter 
of the c-myc gene and to a sequence that is involved 
in the termination of transcription of the com-
plement 2 gene (Bossone  et al., 1992). MAZ 
appears to have a dual role in the initiation and 
termination of transcription (Ashfield  et al., 1994; 
Parks and Shenk, 1997). This TF is expressed ubi-
quitously, but at different levels in different human 
tissues, and its expression appears to be regulated in 
a cell cycle-dependent manner by the MAZ protein 
itself (Song  et al., 1998). 
Recently, we have demonstrated that two out of 
three potential MAZ binding sites within the 
human SOX3 promoter can specifically bind the 
MAZ protein (Kovacevic  Grujicic  et al., 2008). 
Furthermore, we have shown that MAZ acts as a 
positive regulator of SOX3 gene transcription in 
undifferentiated NT2/D1 cells. Here we revealed 
that MAZ has the same effect on the SOX2 
expression. Namely, as shown in Fig. 1B, overex-
pression of MAZ led to the up-regulation of the 
endogenous SOX2 protein level.  
Taken together, here we report that over-
expression of ubiquitous TFs NF-Y, Sp1 and MAZ 
resulted in a mild to significant activation of the 
human SOX2 expression (fold increase from 1.4 to 
2.5; Fig. 1A and B) in the NT2/D1 model system.  
Effect of TALE transcription factors on SOX2 
expression 
The TALE (three amino acid loop extension) sub-
class of homeodomain proteins regulates tran-
scription of many essential developmental genes 
during embryogenesis, acting as either transcrip-
tional activators or repressors (Marquardt, 2003). 
This super-family of DNA-binding proteins 
includes members of the PBX, MEIS, TGIF and 
PKNOX protein families (diIorio  et al., 2007). 
PBX1 (pre-B cell leukemia transcription 
factor 1) belongs to the PBX family of 
transcription factors. They are proposed to act as 
central developmental factors with a role in 
integrating transduction signals (Laurent  et al., 
2008). Namely, it has been shown that PBX 
proteins functionally interact with a wide variety 
of TFs by forming heterodimers, heterotrimers or 
multimers on the promoters of target genes that, 
like SOX2, play key roles in cell fate (reviewed in 
Laurent  et al., 2008).  
Human MEIS1 (myeloid ecotropic viral 
integration site 1 homolog) has been cloned from 
BMH-2 myeloid tumors as a novel common 
oncogenic site of proviral integration (Moskow  et 
al., 1995). In Xenopus laevis, Meis1b regulates 
hindbrain gene expression (Maeda  et al., 2002), 
while the ectopic expression of Meis caudalizes 
neural cell
 fates (Salzberg  et al., 1999).  
In contrast to the activation role of PBX1 and 
MEIS1 proteins, TGIF (5′ -TG-3′  interacting 
factor) functions as a transcriptional repressor 
(Bertolino  et al., 1995).  204 MILENA  MILIVOJEVIĆ  ET AL. 
 
 
Fig. 2.  Effect of TALE TFs on SOX2 protein expression.
Western blot analyses of WCLs from NT2/D1 cells, non-
transfected, or transfected with expression vectors for Pbx1,
Meis1 or TGIF were performed using antibodies specific for 
SOX2 and α-tubulin, as indicated on the right. Quantitation of
SOX2 protein level (relative to non-transfected NT2/D1 cells
which was set as 1) is shown below. 
Using the NT2/D1 model system, we have 
shown that Pbx1 and Meis1 proteins up-regulate 
SOX3 gene expression. Also, overexpression of 
Pbx1 and Meis1 increases  endogenous  SOX3 
protein expression (Mojsin  and  Stevanovic, 2009). 
Contrary to this, TGIF acts as a transcriptional re-
pressor of the SOX3 gene in NT2/D1 cells (Mojsin, 
2008). Results presented here clearly demonstrate 
that Pbx1 and Meis1 cause the same effect on the 
SOX2 expression, i.e., overexpression of each of 
these two TFs in un-induced NT2/D1 cells causes 
considerable up-regulation of the endogenous 
SOX2 protein level (Fig. 2). On the other hand, the 
TGIF transcription factor does not cause any 
significant effect on the SOX2 expression in the 
same model system (Fig. 2).  
Effect of liganded retinoid X receptor on SOX2 
expression 
Retinoic acid (RA) is a naturally occurring vitamin 
A derivative that regulates a broad range of biologic 
processes, with an essential role in neurodevelop-
ment (Maden, 2002). RA mainly exerts its pleio-
tropic effects through the two families of nuclear 
retinoid receptors: RA receptors (RARs; NR1B) and 
retinoid X receptors (RXRs; NR2B), each contai-
ning three different receptor types: α, β, and γ 
(Mangelsdorf  et al., 1995). In response to retinoid 
binding, members of these two receptor families 
form stable heterodimers that modulate the 
transcription of target genes by interacting with cis-
acting RA response elements (RAREs) (Laudet  and  
Gronemeyer, 2002). Also, RXR acts as an obligatory 
heterodimeric partner for a various array of other 
members of the intracellular receptor superfamily 
(Laudet and Gronemeyer, 2002). 
We have shown previously that the human 
SOX3 gene is expressed at low level in undif-
ferentiated NT2/D1 cells, and that a 48 h exposure 
to RA leads to the up-regulation of its expression at 
both mRNA and protein levels (Mojsin  et al., 2006; 
Nikcevic  et al., 2008; Stevanovic, 2003). Further-
more, we have shown that RXRs are the major 
mediators of RA effect on the activation of SOX3 
gene expression. On the other hand, for the SOX2 
gene, a relatively high level of expression is detected 
in undifferentiated NT2/D1 cells, which does not 
significantly change following RA treatment (Deb-
Rinker  et al., 2005).  
Regardless of the fact that the expression 
patterns of the SOX2 and SOX3 genes are different 
during the early phases of RA induced differen-
tiation of NT2/D1 cells, we decided to test the res-
ponse of the SOX2 gene to overexpression of ligan-
ded RXR. As expected, a 48 h treatment of NT2/D1 
cells by RA solely did not cause any significant 
effect on the SOX2 protein level (Fig. 3). However, 
when the nuclear receptor RXRα has been overex-
pressed in the presence of RA a significant increase 
in SOX2 expression has been detected (Fig. 3). The 
observed activation might be the result of a direct 
interaction of RXRα with control element(s) within 
the SOX2 regulatory region. Also, besides this direct 
mediation of RA activity, many other indirect 
effects of RA might be responsible for triggering the 
SOX2 up-regulation under the described con-
ditions. One of them, for example, could be linked 
to the Wnt signaling pathway. Namely, it has been 
shown that RA treatment leads to a decrease in the 
activity of the Wnt signaling, i.e. the TCF/LEF-
mediated transactivation, in several cell lines (Eas- 
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Fig. 3.  Liganded RXRα up-regulates human SOX2 protein
expression. Western blot analyses of WCLs from untreated and
RA-treated NT2/D1 cells, either in the absence or presence of
RXRα expression vector, were performed using antibodies
specific for SOX2 and α-tubulin, as indicated on the right.
Quantitation of SOX2 protein level (relative to non-transfected 
NT2/D1 cells which was set as 1) is shown below. 
waran et al., 1999). Furthermore, it has been shown 
that Tcf3, a member of the Tcf/Lef family and a 
component of the Wnt signaling pathway, partially 
reduces expression of the three pluripotency regu-
lators, Oct4, Sox2, and Nanog in mES cells (Cole  et 
al., 2008). Therefore, we can speculate that RA 
treatment of NT2/D1 cells in the presence of excess 
nuclear retinoid receptor could lead to a reduced 
activity of TCF signaling, which in turn would cause 
the partial relief of the suppression of the SOX2 gene 
expression, resulting in an increase of the SOX2 pro-
tein level. It is interesting to point out that previous 
comparative  in silico analysis revealed a conserved 
TCF/LEF binding site among human, rat and mouse 
Sox2 promoters (Katoh and Katoh, 2005). 
In silico analysis of the human SOX2 promoter 
Despite the fact that a number of far-distant re-
gulatory elements and corresponding TFs respon-
sible for the SOX2 gene expression have been iden-
tified, it is not entirely revealed how the expression 
of this gene is regulated. Previous functional 
analyses of the mouse Sox2 promoter revealed that 
the region from -528 to +238 relative to the 
transcriptional start point (tsp) contains regulatory 
elements capable of activating gene transcription 
(Wiebe  et al., 2000) (Fig. 4a). It has also been 
shown that a smaller region, located between -426 
to +9, is able to regulate Sox2 gene expression 
(Lengler  et al., 2005), (Fig. 4b). However, the pro-
moter region of the human SOX2 gene has not been 
characterized. 
 
 
Fig. 4. Schematic overview of Sox2/SOX2 promoters. (a) Murine Sox2 promoter analyzed by Wiebe et al., 2000. (b) Murine Sox2
promoter analyzed by Lengler et al.(2005). (c) Human SOX2 promoter predicted by PromoterInspector software. Numbers above 
fragments indicate the end positions of promoter regions relative to murine tsp that is designated as +1 (tsp). Numbers below 
fragments indicate the end positions of promoter regions relative to adenosine in the first ATG codon of the human SOX2, denoted 
as +1 (ATG). 206 MILENA  MILIVOJEVIĆ  ET AL. 
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Based on data described by Wiebe et al., (Wiebe  
et al., 2000), we performed the bioinformatic 
analysis of the 5'-flanking region of the human 
SOX2  gene (human genome sequence 
NT_005612.16). The PromoterInspector software 
revealed that the predicted SOX2 promoter is 
positioned 948 bp upstream and 102 bp down-
stream from the adenosine in the first ATG codon 
denoted as +1 (nucleotide position from 87924351 
to 87925400 of human genome sequence 
NT_005612.16) (Fig. 4c).  
Our next goal was to compare the predicted 
human SOX2 promoter sequence with the corres-
ponding 5' flanking sequence of the mouse 
orthologue using a bioinformatics tools. Namely, 
we sought to identify the evolutionary conserved 
motifs and important cis-regulatory elements bet-
ween the promoter regions of SOX2/Sox2 genes 
with respect to factors which we have shown to be 
relevant to human SOX3 and SOX2 gene expression 
(NF-Y, Sp1, MAZ, Pbx1, Meis1 and RXRα). 
Alignment of the promoter sequences of 
Fig. 5.  (A).  In silico analysis of human and mouse SOX2/Sox2  promoter regions. The binding sites for transcription factors, 
previously shown to be involved in the regulation of human SOX3 gene expression (NF-Y, Sp1, MAZ, PBX, MEIS and RXR) are 
indicated above the aligned sequences. The translational start point is designated as +1 and represented by filled arrow. Murine Sox2
tsp, as determined by Wiebe et al., (2000) is represented by dotted arrow. Homo-human (Homo sapiens); Mus-mouse (Mus 
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SOX2/Sox2 genes using ClustalW and GeneDoc 
software revealed a significant level of their 
conservation during evolution (80% sequence 
identity) (Fig. 5A). Furthermore, results of 
Matlnspector analysis pointed to a cluster of four 
TFs (Sp1, PBX1, NF-Y and MEIS1), closely located 
to the mouse tsp that are highly conserved in 
sequence and in position, among the analyzed hu-
man and mouse promoters (Fig. 5A and B). Also, 
an up-stream RXR binding site is conserved, as well 
as two Sp1 binding sites down-stream from the 
mouse tsp (Fig. 5A and B). This in silico analysis 
supports our Western blot results showing the 
involvement of selected TFs in the regulation of 
SOX2 expression, particularly since it has been 
postulated that non-coding sequences that can be 
aligned across two or more organisms could have 
functional regulatory roles (Boffelli  et al., 2003). 
Apart from the conserved sites, our analysis re-
vealed some differences in the number and position 
of putative binding sites for transcription factors 
Sp1, MAZ, Pbx1 and RXR (Fig. 5A and B).  
Taken together, we have presented data indi-
cating that some aspects of the transcriptional regu-
lation of SOX2 and SOX3 genes are preserved. Simi-
larly to SOX3, we report here on the activation of 
SOX2 expression by ubiquitous TFs (NFY, Sp1 and 
MAZ) by TALE family members (Pbx1 and Meis1), 
as well as liganded RXRα. On the other hand, TGIF 
is the only analyzed TF whose overexpression in 
NT2/D1 cells caused a different response in SOX3 
and SOX2 expression. Namely, TGIF acted as a 
transcriptional repressor of the SOX3 gene, while 
no significant effect of this TF on the SOX2 ex-
pression has been revealed in this study.  
Data presented here could help in a better un-
derstanding of the molecular mechanism(s) respon-
sible for the regulation of expression of the SOX2 
gene in a human EC model system.  This line of 
research is very important, given the essential role 
of SOX2 in diverse developmental settings, both 
physiological and pathological. Namely, it has been 
shown that SOX2 is implicated in the normal deve-
lopment of the brain and the pituitary gland, as well 
as of the eyes and inner ear (Kelberman  et al., 
2006). Also, it has been reported that heterozygous 
SOX2 mutations in humans cause hippocampal 
defects, forebrain abnormalities and anophthalmia 
(Kelberman  et al., 2006).   
Therefore, the knowledge gained by studying 
genes that participate in maintaining or modifying 
ES/EC cell states, such as SOX2, could open up new 
possibilities in therapies, particularly those related to 
the replacement of lost cells ,  e i t h e r  b y  c e l l  t r a n s -
plantation or by the manipulation of a patient’s pro-
genitor cells in situ. Since the experimental model 
used in this study are NT2 EC cells, it is worth high-
lighting that they have been used for transplantation 
as cell therapy for brain injury, ischemia and 
neurodegenerative diseases in animal models, as well 
as in two clinical trials with human stroke patients 
(reviewed in Newman  et al., 2005). In that respect, 
we believe that elucidating components involved in 
the regulation of SOX genes expression, and SOX2 in 
particular, in a human EC model system could 
provide a valuable contribution to this field. 
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УТИЦАЈ ОПШТИХ ТРАНСКРИПЦИОНИХ ФАКТОРА, TALE ПРОТЕИНА И ЛИГАНДОМ 
АКТИВИРАНОГ НУКЛЕАРНОГ РЕЦЕПТОРА RXRα НА РЕГУЛАЦИЈУ ЕКСПРЕСИЈЕ ХУМАНОГ 
SOX2 ГЕНА У ЕМБРИОНАЛНОЈ КАРЦИНОМСКОЈ NT2/D1 ЋЕЛИЈСКОЈ ЛИНИЈИ 
МИЛЕНА МИЛИВОЈЕВИЋ, ГОРДАНА НИКЧЕВИЋ, НАТАША КОВАЧЕВИЋ-ГРУЈИЧИЋ, 
А. КРСТИЋ, МАРИЈА МОЈСИН, ДАНИЈЕЛА ДРАКУЛИЋ
 и МИЛЕНА СТЕВАНОВИЋ 
Институт за молекуларну генетику и генетичко инжењерство, Универзитет у Београду, 11010 Београд, Србија 
SOX2 транскрипциони фактор има кључну 
улогу у процесима ембрионалног развића и 
представља универзални маркер плурипотент-
них матичних ћелија. С обзиром на функцио-
налну редундантност и преклапајући профил 
експресије чланова SOXB1 подгрупе током 
развића, циљ овог рада био је да испита потен-
цијалне заједничке аспекте регулације експре-
сије  SOX2 и SOX3 гена. Наиме, испитиван је 
утицај одабраних транскрипционих фактора на 
регулацију експресије SOX2 гена у NT2/D1 
ћелијској линији. Анализирани су они фактори 
за које је претходно показано да су укључени у 
модулацију активности хуманог SОX3 гена. Ре-
зултати ових истраживања указују да општи 
транскрипциони фактори (NF-Y, Sp1 и MAZ), 
чланови TALE фамилије протеина (Pbx1 и 
Meis1), као и ретиноичном киселином акти-
виран нуклеарни рецептор RXRα доводе до 
повећане експресије  SОX2 протеина. Испити-
вање транскрипционих фактора укључених у ре-
гулацију експресије SОX гена је значајно за боље 
разумевање сигналних путева који су активни у 
плурипотентним матичним ћелијама. 
 